We are live on ! Find out more
CRBU icon

Caribou Biosciences
CRBU

120 hedge funds and large institutions have $203M invested in Caribou Biosciences in 2022 Q2 according to their latest regulatory filings, with 31 funds opening new positions, 34 increasing their positions, 34 reducing their positions, and 14 closing their positions.

New
Increased
Maintained
Reduced
Closed

466% more call options, than puts

Call options by funds: $1.06M | Put options by funds: $188K

121% more first-time investments, than exits

New positions opened: 31 | Existing positions closed: 14

15% more funds holding

Funds holding: 104 → 120 (+16)

5.28% more ownership

Funds ownership: 56.22% → 61.5% (+5.3%)

0% more repeat investments, than reductions

Existing positions increased: 34 | Existing positions reduced: 34

33% less funds holding in top 10

Funds holding in top 10: 3 → 2 (-1)

35% less capital invested

Capital invested by funds: $313M → $203M (-$110M)

Holders
120
Holders Change
+16
Holders Change %
+15.38%
% of All Funds
2.02%
Holding in Top 10
2
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-33.33%
% of All Funds
0.03%
New
31
Increased
34
Reduced
34
Closed
14
Calls
$1.06M
Puts
$188K
Net Calls
+$877K
Net Calls Change
+$712K

Top Buyers

Rank Fund Capital Flow
1
PHS
PFM Health Sciences
California
+$12.5M
2
Assenagon Asset Management
Assenagon Asset Management
Luxembourg
+$8.48M
3
RCMU
Rokos Capital Management (UK)
United Kingdom
+$8.09M
4
BlackRock
BlackRock
New York
+$5.59M
5
Morgan Stanley
Morgan Stanley
New York
+$3.37M

Top Sellers

Rank Fund Capital Flow
1
MIM
Monashee Investment Management
Massachusetts
-$4.32M
2
Fidelity Investments
Fidelity Investments
Massachusetts
-$3.74M
3
FCM
Farallon Capital Management
California
-$3.46M
4
Alkeon Capital Management
Alkeon Capital Management
New York
-$2.68M
5
Citadel Advisors
Citadel Advisors
Florida
-$2.23M
Name Holding Trade Value Shares
Change 		Change in
Stake
GAA
26
Green Alpha Advisors
Colorado
$1.37M +$1.55M +202,598 +408%
Renaissance Technologies
27
Renaissance Technologies
New York
$1.3M +$718K +93,900 +65%
Mirae Asset Global Investments
28
Mirae Asset Global Investments
South Korea
$1.19M +$516K +67,500 +45%
VCIM
29
Velan Capital Investment Management
Georgia
$1.14M – – –
Charles Schwab
30
Charles Schwab
California
$1.13M -$56K -7,326 -3%
SCM
31
Shelton Capital Management
Colorado
$988K – – –
ROTUOC
32
Regents of the University of California
California
$984K – – –
Bank of New York Mellon
33
Bank of New York Mellon
New York
$799K +$45.3K +5,923 +4%
Goldman Sachs
34
Goldman Sachs
New York
$761K -$1.06M -139,140 -50%
FC
35
Franchise Capital
Cayman Islands
$670K +$944K +123,436 New
Swiss National Bank
36
Swiss National Bank
Switzerland
$621K +$439K +57,400 +101%
AG
37
Artal Group
Luxembourg
$572K – – –
LP
38
LMR Partners
United Kingdom
$516K +$650K +85,000 +850%
NCM
39
Nelson Capital Management
California
$462K +$154K +20,162 +31%
LFCM
40
Long Focus Capital Management
Puerto Rico
$434K +$612K +80,000 New
RhumbLine Advisers
41
RhumbLine Advisers
Massachusetts
$415K +$214K +27,980 +58%
Bank of America
42
Bank of America
North Carolina
$397K +$410K +53,570 +274%
Ensign Peak Advisors
43
Ensign Peak Advisors
Utah
$384K – – –
BG
44
Bellevue Group
Switzerland
$382K +$537K +70,300 New
SAM
45
Stansberry Asset Management
Texas
$376K -$179K -23,451 -25%
WP
46
Woodline Partners
California
$374K – – –
Citadel Advisors
47
Citadel Advisors
Florida
$358K -$2.23M -291,526 -82%
California State Teachers Retirement System (CalSTRS)
48
California State Teachers Retirement System (CalSTRS)
California
$349K +$169K +22,162 +53%
UBS AM
49
UBS AM
Illinois
$337K +$242K +31,718 +105%
ECM
50
ExodusPoint Capital Management
New York
$295K +$415K +54,344 New
1
2
3 4 5

CRBU Hedge Fund Activity: Q2 2022 in Review

120 of the 5,936 institutional investors tracked by Wall St. Rank reported a position in Caribou Biosciences (CRBU) for Q2 2022, worth a combined $203M — down 35% from $313M a quarter earlier.

Buyers outnumbered sellers: 31 funds opened new CRBU positions and 14 closed out — a net gain of 17 holders — while 34 added to existing stakes and 34 trimmed.

The largest buyer was PFM Health Sciences, adding an estimated $12.5M. The largest seller was Monashee Investment Management, exiting entirely with an estimated $4.32M sold.

  • 120 institutional investors held Caribou Biosciences (CRBU) as of Q2 2022, up from 104 in Q1 2022.
  • Funds reported $203M of Caribou Biosciences stock for Q2 2022, down 35% quarter-over-quarter.
  • 31 funds opened new Caribou Biosciences positions in Q2 2022 and 14 closed out, a net change of +17 holders.
  • The largest Caribou Biosciences buyer in Q2 2022 was PFM Health Sciences, an estimated $12.5M added.
  • The largest Caribou Biosciences seller in Q2 2022 was Monashee Investment Management, an estimated $4.32M sold.

Based on aggregated 13F filings for Q2 2022.